Magnetar Financial LLC acquired a new stake in Humana Inc. (NYSE:HUM - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 59,937 shares of the insurance provider's stock, valued at approximately $15,207,000.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Quest Partners LLC bought a new stake in Humana in the 3rd quarter valued at about $701,000. Banque Cantonale Vaudoise increased its position in Humana by 8.9% in the 3rd quarter. Banque Cantonale Vaudoise now owns 11,387 shares of the insurance provider's stock valued at $3,606,000 after buying an additional 927 shares in the last quarter. B. Metzler seel. Sohn & Co. Holding AG bought a new stake in Humana in the 3rd quarter valued at about $1,778,000. Jennison Associates LLC increased its position in Humana by 4.4% in the 3rd quarter. Jennison Associates LLC now owns 333,725 shares of the insurance provider's stock valued at $105,704,000 after buying an additional 13,945 shares in the last quarter. Finally, Ontario Teachers Pension Plan Board increased its position in Humana by 6.5% in the 3rd quarter. Ontario Teachers Pension Plan Board now owns 1,173,535 shares of the insurance provider's stock valued at $371,705,000 after buying an additional 71,910 shares in the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of analysts have commented on HUM shares. Barclays boosted their price objective on Humana from $255.00 to $270.00 and gave the stock an "equal weight" rating in a report on Thursday, February 13th. Morgan Stanley decreased their price objective on Humana from $301.00 to $285.00 and set an "equal weight" rating for the company in a report on Wednesday, February 12th. JPMorgan Chase & Co. decreased their price objective on Humana from $257.00 to $256.00 and set a "neutral" rating for the company in a report on Tuesday, February 18th. StockNews.com lowered Humana from a "buy" rating to a "hold" rating in a report on Tuesday. Finally, Cantor Fitzgerald reissued a "neutral" rating and set a $290.00 price objective on shares of Humana in a report on Wednesday, February 12th. Nineteen research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of "Hold" and an average price target of $285.68.
Check Out Our Latest Stock Report on Humana
Insiders Place Their Bets
In other Humana news, insider Timothy S. Huval sold 3,703 shares of the stock in a transaction on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the sale, the insider now owns 8,181 shares in the company, valued at $2,096,463.06. This represents a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Company insiders own 0.37% of the company's stock.
Humana Stock Performance
Humana stock traded down $0.50 during trading on Friday, hitting $266.33. The stock had a trading volume of 1,963,596 shares, compared to its average volume of 1,713,717. Humana Inc. has a 1 year low of $213.31 and a 1 year high of $406.46. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. The stock's 50 day moving average is $271.33 and its two-hundred day moving average is $277.52. The stock has a market cap of $32.14 billion, a price-to-earnings ratio of 26.77, a price-to-earnings-growth ratio of 2.05 and a beta of 0.57.
Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. As a group, analysts predict that Humana Inc. will post 16.47 EPS for the current year.
Humana Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be given a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, March 28th. This represents a $3.54 annualized dividend and a dividend yield of 1.33%. Humana's dividend payout ratio is currently 35.58%.
About Humana
(
Free Report)
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Further Reading
Before you consider Humana, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Humana wasn't on the list.
While Humana currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
